Authors: MILLER AE MORGANTE LA

Citation: Ae. Miller et La. Morgante, PATIENT CHOICE OF FDA-APPROVED IMMUNOTHERAPIES FOR MULTIPLE-SCLEROSIS, Neurology, 50(4), 1998, pp. 47004-47004

Authors: MILLER AE MORGANTE LA BUCHWALD LY COYLE PK KRUPP LB DOSCHER CA LUBLIN FD KNOBLER RL TRANTAS F KELLEY L SMITH CR LAROCCA N LOPEZ S

Citation: Ae. Miller et al., A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS, Neurology, 48(2), 1997, pp. 312-314

Authors: MILLER AE MORGANTE LA BUCHWALD LY NUTILE SM COYLE PK KRUPP LB DOSCHER CA LUBLIN FD KNOBLER RL TRANTAS F KELLEY L SMITH CR LAROCCA N LOPEZ S

Citation: Ae. Miller et al., A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 436-436